← Back to headlines
Lonza Predicts Big Pharma May Delay Outsourcing Amid US Investments
Lonza has indicated that major pharmaceutical companies might postpone their outsourcing decisions, influenced by ongoing investments within the United States.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
